Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medical Imaging
Published in: BMC Medical Imaging 1/2019

Open Access 01-12-2019 | Giant Cell Arteritis | Research article

RETRACTED ARTICLE: Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study

Authors: Quan Zou, Sumei Ma, Xinghu Zhou

Published in: BMC Medical Imaging | Issue 1/2019

Login to get access

Abstract

Background

Diagnosis of giant cell arteritis by temporal artery biopsy is time-consuming and visual loss lies in the first week after its diagnosis. The purpose of the study was to test the hypothesis that ultrasound can reduce the risk of overdiagnosis and overtreatment in giant cell arteritis.

Methods

Data regarding physical/ clinical features examinations, temporal artery biopsy examinations, ultrasound findings, and magnetic resonance imaging examinations of 980 suspected patients for giant cell arteritis were included in the study. Decision curve analysis was applied to get a beneficial score for selected diagnostic modalities. Cost analysis was performed for each patient.

Results

Fewer numbers of false positive giant cell arteritis results were reported under physical/ clinical features examinations following ultrasound detection than physical/clinical features examinations following temporal artery biopsy examinations (45 vs. 127, p < 0.0001). The working area that detects giant cell arteritis at least one time for physical/ clinical features examinations following ultrasound detection and physical/ clinical features examinations following temporal artery biopsy examinations were 0–91% and 0–86%. No significant difference for true negative results between magnetic resonance imaging and physical and clinical features examinations following ultrasound detection (p = 0.007). Physical and clinical features examinations following ultrasound detection were less expensive method than physical/ clinical features examinations following temporal artery biopsy examinations (14,023 ± 982 ¥/patient vs. 18,551 ± 1231 ¥/patient, p < 0.0001) and MRI.

Conclusion

Physical and clinical features examinations following ultrasound are recommended for diagnosis of patients with suspected giant cell arteritis.
Literature
1.
Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W, Masters S, McDonald B, McNally E, Pease C, Piper J, Salmon J, Wailoo A, Wolfe K, Hutchings A. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess. 2016;20:1–238.CrossRefPubMedPubMedCentral
2.
3.
Ing EB, Lahaie Luna G, Toren A, Ing R, Chen JJ, Arora N, Torun N, Jakpor OA, Fraser JA, Tyndel FJ, Sundaram AN, Liu X, Lam CT, Patel V, Weis E, Jordan D, Gilberg S, Pagnoux C, Ten Hove M. Multivariable prediction model for suspected giant cell arteritis: development and validation. Clin Ophthalmol. 2017;11:2031–42.CrossRefPubMedPubMedCentral
4.
5.
Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, Fulcher J, Hollywood J, Hutchings A, James P, Kyle V, Nott J, Power M, Samanta A. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology. 2010;49:1594–7.CrossRefPubMed
6.
Nesher G. The diagnosis and classification of giant cell arteritis. J Autoimmun. 2014;48–49:73–5.CrossRefPubMed
7.
Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology. 2016;55:66–70.CrossRefPubMed
8.
Danesh-Meyer H, Savino PJ, Gamble GG. Poor prognosis of visual outcome after visual loss from giant cell arteritis. Ophthalmology. 2005;112:1098–103.CrossRefPubMed
9.
Banerjee PJ, Petrou P, Plant GT. Diagnostic and treatment challenges in giant cell arteritis. Lancet. 2014;383:2210.CrossRefPubMed
10.
Dunstan E, Lester SL, Rischmueller M, Dodd T, Black R, Ahern M, Cleland LG, Roberts-Thomson P, Hill CL. Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J. 2014;44:32–9.CrossRefPubMed
11.
Diamantopoulos AP, Haugeberg G, Hetland H, Soldal DM, Bie R, Myklebust G. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res. 2014;66:113–9.CrossRef
12.
Siemonsen S, Brekenfeld C, Holst B, Kaufmann-Buehler AK, Fiehler J, Bley TA. 3T MRI reveals extra- and intracranial involvement in giant cell arteritis. Am J Neuroradiol. 2015;36:91–7.CrossRefPubMedPubMedCentral
13.
Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology. 2008;47:96–101.CrossRefPubMed
14.
15.
Laria A, Lurati A, Scarpellini M. Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up. Open Access Rheumatol. 2017;9:55–9.CrossRefPubMedPubMedCentral
16.
Klink T, Geiger J, Both M, Ness T, Heinzelmann S, Reinhard M, Holl-Ulrich K, Duwendag D, Vaith P, Bley TA. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology. 2014;273:844–52.CrossRefPubMed
17.
Fitzgerald M, Saville BR, Lewis RJ. Decision curve analysis. JAMA. 2015;13:409–10.CrossRef
18.
Seeliger B, Sznajd J, Robson JC, Judge A, Craven A, Grayson PC, Suppiah RS, Watts RA, Merkel PA, Luqmani RA. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology. 2017;56:1154–61.CrossRefPubMedPubMedCentral
19.
Bley TA, Reinhard M, Hauenstein C, Markl M, Warnatz K, Hetzel A, Uhl M, Vaith P, Langer M. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008;58:2574–8.CrossRefPubMed
20.
Patil P, Achilleos K, Williams M, Maw W, Dejaco C, Borg F, Gupta S, Dasgupta B. Outcomes and cost-effectiveness analysis of fast track pathway in giant cell arteritis. Rheumatology. 2014;53:i5–6.CrossRef
21.
Patil P, Williams M, Maw WW, Achilleos K, Elsideeg S, Dejaco C, Borg F, Gupta S, Dasgupta B. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol. 2015;33:S–103–6.PubMed
22.
23.
Schmidt WA. Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology. 2018;57:ii22–31.CrossRefPubMed
24.
Abdul-Rahman AM, Molteno AC, Bevin TH. The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Z Med J. 2011;124:44–52.PubMed
25.
Bas-Lando M, Breuer GS, Berkun Y, Mates M, Sonnenblick M, Nesher G. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol. 2007;25:S15–7.PubMed
26.
McLachlan RHP, Lennox AF, Varcoe RL, Thomas SD. Endovascular treatment of critical lower limb ischemia caused by giant cell arteritis. J Vasc Surg Cases Innov Tech. 2019;5:31–4.CrossRefPubMedPubMedCentral
27.
Bley TA, Geiger J, Jacobsen S, Wieben O, Markl M, Vaith P, Grist T, Langer M, Uhl M. High-resolution MRI for assessment of middle meningeal artery involvement in giant cell arteritis. Ann Rheum Dis. 2009;68:1369–70.CrossRefPubMed
Metadata
Title
RETRACTED ARTICLE: Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study
Authors
Quan Zou
Sumei Ma
Xinghu Zhou
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Medical Imaging / Issue 1/2019
Electronic ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-019-0344-2

Other articles of this Issue 1/2019

BMC Medical Imaging 1/2019 Go to the issue

Research article

Unenhanced multidetector computed tomography findings in acute central pulmonary embolism

Research article

Comparison of different registration methods and landmarks for image-guided radiation therapy of pulmonary tumors

Case report

Adding trans-abdominal elastography to the diagnostic tool for an ileal gastrointestinal stromal tumor: a case report

Technical advance

Time-lapse angiography of the ocular fundus: a new video-angiography

Research article

Multi-atlas active contour segmentation method using template optimization algorithm

Research article

Relation between carotid vulnerable plaques and peripheral leukocyte: a case-control study of comparison utilizing multi-parametric contrast-enhanced ultrasound